126 related articles for article (PubMed ID: 31354289)
1. Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma.
Yue C; Liang C; Ge H; Yan L; Xu Y; Li G; Li P; Wei Z; Wu J
Onco Targets Ther; 2019; 12():4555-4566. PubMed ID: 31354289
[No Abstract] [Full Text] [Related]
2. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
Han K; Li C; Zhang X; Shang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
[TBL] [Abstract][Full Text] [Related]
3. Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
Yue C; Ren Y; Ge H; Yan L; Xu Y; Wang G; Wu J
J Cell Physiol; 2019 Dec; 234(12):23685-23694. PubMed ID: 31169303
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.
Xu Y; Yu X; Wei C; Nie F; Huang M; Sun M
J Exp Clin Cancer Res; 2018 Jan; 37(1):13. PubMed ID: 29374493
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
Lv XY; Ma L; Chen JF; Yu R; Li Y; Yan ZJ; Cheng Y; Ma Q
Int J Oncol; 2018 Jan; 52(1):288-294. PubMed ID: 29115412
[TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNAs DUXAP9 and DUXAP10 is associated with prognosis in patients with hepatocellular carcinoma after hepatectomy.
Zhu Q; Liu J; Tang J; Guo DL; Li Y; Duan R
Int J Clin Exp Pathol; 2018; 11(3):1407-1414. PubMed ID: 31938237
[TBL] [Abstract][Full Text] [Related]
9. Highly expressed long non-coding RNA DUXAP10 promotes proliferation of ovarian cancer.
Zhang Q; Wang WW; Xu TH; Xu ZF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):314-321. PubMed ID: 29424918
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value and Molecular Regulatory Mechanism of MSTO2P in Hepatocellular Carcinoma: A Comprehensive Study Based on Bioinformatics, Clinical Analysis and in vitro Validation.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Onco Targets Ther; 2020; 13():2583-2598. PubMed ID: 32273728
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer.
Lian Y; Xiao C; Yan C; Chen D; Huang Q; Fan Y; Li Z; Xu H
J Cell Biochem; 2018 Apr; 119(4):3671-3682. PubMed ID: 29286182
[TBL] [Abstract][Full Text] [Related]
12. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
Zhang Z; Zhu J; Huang Y; Li W; Cheng H
Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
[TBL] [Abstract][Full Text] [Related]
13. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
Zheng YF; Zhang XY; Bu YZ
J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA DUXAP10 promotes the proliferation, migration, and inhibits apoptosis of prostate cancer cells.
Wang XF; Chen J; Gong YB; Qin YC; Wang L; Li NC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3699-3708. PubMed ID: 31114994
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.
Sun F; Wang J; Sun Q; Li F; Gao H; Xu L; Zhang J; Sun X; Tian Y; Zhao Q; Shen H; Zhang K; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):449. PubMed ID: 31684995
[TBL] [Abstract][Full Text] [Related]
16. DUXAP10 regulates proliferation and apoptosis of chronic myeloid leukemia via PTEN pathway.
Yao R; Feng WT; Xu LJ; Zhong XM; Liu H; Sun Y; Zhou LL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4934-4940. PubMed ID: 30070329
[TBL] [Abstract][Full Text] [Related]
17. The pseudogene derived from long non-coding RNA DUXAP10 promotes colorectal cancer cell growth through epigenetically silencing of p21 and PTEN.
Lian Y; Xu Y; Xiao C; Xia R; Gong H; Yang P; Chen T; Wu D; Cai Z; Zhang J; Wang K
Sci Rep; 2017 Aug; 7(1):7312. PubMed ID: 28779166
[TBL] [Abstract][Full Text] [Related]
18. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
19. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
[TBL] [Abstract][Full Text] [Related]
20. DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
Zhu M; Wu M; Bian S; Song Q; Xiao M; Huang H; You L; Zhang J; Zhang J; Cheng C; Ni W; Zheng W
Cell Biosci; 2021 Feb; 11(1):42. PubMed ID: 33622397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
